Oragenics Inc - ESG Rating & Company Profile powered by AI
Alternative corporations in the scoring industry group for Oragenics Inc are displayed below. If you are employed by Oragenics Inc and you would like to use your ESG aseessment, please contact us. The webpage is a free E,S&G report for Oragenics Inc.
Oragenics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.8; made up of an environmental score of 5.3, social score of 8.0 and governance score of 4.0.
5.8
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 521 | Smruthi Organics Ltd | 5.9 | High |
| 521 | Vectura Group PLC | 5.9 | High |
| 541 | Oragenics Inc | 5.8 | High |
| 541 | Cantargia AB | 5.8 | High |
| 541 | Amplia Therapeutics Ltd | 5.8 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Oragenics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Oragenics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Oragenics Inc report the average age of the workforce?
Sign up for free to unlockDoes Oragenics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Oragenics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Oragenics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Oragenics Inc offer flexible work?
Sign up for free to unlockDoes Oragenics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Oragenics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Oragenics Inc conduct supply chain audits?
Sign up for free to unlockDoes Oragenics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Oragenics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Oragenics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Oragenics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Oragenics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Oragenics Inc disclose water use targets?
Sign up for free to unlockDoes Oragenics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Oragenics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Oragenics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Oragenics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Oragenics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Oragenics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Oragenics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Oragenics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Oragenics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Oragenics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Oragenics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Oragenics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Oragenics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Oragenics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Oragenics Inc disclose its waste policy?
Sign up for free to unlockDoes Oragenics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Oragenics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Oragenics Inc disclose energy use targets?
Sign up for free to unlockDoes Oragenics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Oragenics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Oragenics Inc
These potential risks are based on the size, segment and geographies of the company.
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus. The company's product candidates also comprise LPT3-04, a weight loss candidate; and SMaRT Replacement Therapy, a topical treatment to prevent dental carries. It has a license agreement with Noachis Terra Inc. for licensing of certain specified patent rights and biological materials relating to the use of pre-fusion coronavirus spike proteins; and a collaboration agreement with Precigen, Inc. and ILH Holdings, Inc. for the development and commercialization of MU1140 and related homologs. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida.